A comprehensive, 80+-slide analysis providing clear, practical and insight-driven guidance to help oncology market access teams navigate HTA, pCPA negotiations, and payer expectations with confidence.

Overview

The Canadian oncology market access continues to evolve, shaped by maturing HTA methods, expedited Project Orbis pathways, shifting pCPA dynamics, and increasing pressure on both value and affordability. This report offers practical guidance grounded in detailed analysis, designed specifically for global and Canadian pharma teams responsible for assessing market potential, planning launch forecasts, and developing market access strategies.

Built from MORSE Consulting’s extensive experience and ongoing monitoring of HTA recommendations, pricing, and pCPA outcomes, this 100+-slide report provides a realistic view of how oncology products are assessed, negotiated, and ultimately reimbursed in Canada.

What This Report Provides

A practical, system-minded perspective on: 

  1. HTA Assessment Trends
  • Analysis of drivers behind positive vs. negative oncology recommendations 
  • Review of key themes in recent CDA-AMC and INESSS reviews  
  • Examination of how evidence gaps and clinical uncertainty impact final outcomes, including real-world examples 
  1. pCPA Negotiation Dynamics
  • Differentiation between oncology and non-oncology negotiation pathways, including accelerated access policies & pathways (Target Zero, ENP, FAST) 
  • Analysis of typical timeframes, common negotiation approaches and outcome structures 
  • Insights into the balance between clinical value, cost-effectiveness, feasibility, and budget impact and impact towards achieving successful negotiations 
  1. Payer and System Considerations
  • Overview of current pressures facing Canadian public drug plans 
  • Discussion on provincial implementation variability following a letter of intent (LOI) 
  • The interplay between payer decision making, affordability, and unmet need 
  1. Forecasting & Net Price Guidance
  • Methodologies for estimating realistic oncology net prices in the current environment 
  • Frameworks for building robust forecast assumptions 
  • Practical examples to support internal planning and scenario modelling 

Who This Report Is For 

Designed for pharma market access teams at both the global and Canadian affiliate level, including: 

  • Market Access & Government Affairs 
  • Pricing Strategy 
  • HEOR 
  • Forecasting & Commercial Planning 

 

Why MORSE Consulting 

MORSE is known across the industry for being: 

  • Credible, and evidence-based: Guidance grounded in data analysis and rigorous monitoring 
  • Specialized Expertise: A focused team with deep experience in Canadian oncology market access 
  • System Perspective: A commitment to understanding the needs of all stakeholders, and the broader health care system. 

Included With Your Purchase: 1-Hour Expert Q&A Session 

To support teams in applying the report’s insights to their oncology assets, each purchase includes a complimentary 1-hour virtual Q&A session with a MORSE oncology expert. 

This session can be used to explore: 

  • HTA evidence expectations and potential pathways 
  • Oncology-specific pCPA negotiation considerations 
  • Timing assumptions from HTA → pCPA → provincial listings 
  • Approaches to developing realistic oncology net price expectations 
  • Implications for forecasting, launch planning, or competitive assets 

This dedicated discussion ensures your team can translate insights into actionable planning. 

 Pricing & Access 

The Oncology Market Access Trends & Insights Report is available for purchase. To request a detailed Table of Contents or pricing information fill out the form on this page.

  • Canadian Reimbursement Forecasting Timelines Report
  • Canadian Reimbursement Forecasting Timelines Report 1

For further information, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.


We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

Oncology Market Access Trends & Insights
Learn More
Learn More